Skip to main content
Log in

Hypotensive and bradycardic effects of talipexole (B-HT 920) in anaesthetized rabbits are antagonized by metoclopramide but not by yohimbine

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

The interactions of talipexole (B-HT 920) and clonidine with selective α-adrenoceptor antagonists, yohimbine (a 2) and prazosin (a 1), as well as with dopamine receptor antagonists, metoclopramide (D2), domperidone (D2) and SCH23 390 (D1) were investigated in anaesthetized rabbits after i. v. administration.

Both talipexole (0.03–0.1 mg/kg) and clonidine (0.01–0.03 mg/kg) dose-dependently induced hypotension and bradycardia. Talipexole had a shorter duration of action.

The hypotensive effect of the α2-adrenoceptor and D2 agonist talipexole (0.03 mg/kg) was antagonized by pretreatment with metoclopramide (3 mg/kg) or domperidone (0.3–3 mg/kg),but not with yohimbine (3 mg/kg),prazosin (0.1 mg/kg) orSCH 23 390 (1 mg/kg). Its bradycardic effect was antagonized only by metoclopramide (3 mg/kg). The hypotensive and bradycardic effects of clonidine (0.03 mg/kg) were most effectively antagonized by yohimbine (0.3–3 mg/kg).

These findings indicate that in anaesthetized rabbits after i. v. administration, talipexole may lower blood pressure by peripheral, and heart rate by central, dopamine D2 agonism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Andén NE, Grabowska-Anden M (1988) Stimulation of D1 dopamine receptors reveals direct effects of the preferential dopamine autoreceptor agonist B-HT 920 on postsynaptic dopamine receptors. Acta Physiol Scand 134:285–290

    Google Scholar 

  • Andén NE, Grabowska-Anden M (1990) B-HT 920 is a full agonist at both pre- and postsynaptic D-2 dopamine receptors. J Neural Transm 79:209–214

    Google Scholar 

  • Andén NE, Golembiowska-Nikitin K, Thornström U (1982) Selective stimulation of dopamine and noradrenaline autoreceptors by BHT 920 and B-HT 933, respectively. Naunyn-Schmiedeberg's Arch Pharmacol 321:100–104

    Google Scholar 

  • Andén NE, Golembiowska-Nikitin K, Nilsson H, Ros E, Thornström U (1983a) Effects of two azepine derivatives (B-HT 920 and BHT 933) on pre- and postsynaptic dopamine receptors in the brain. Acta Pharm Suec Suppl 1:154–164

    Google Scholar 

  • Andén NE, Nilsson H, Ros E, Thornström U (1983b) Effects of BHT 920 and B-HT 933 on dopamine and noradrenaline autoreceptors in the rat brain. Acta Pharmacol Toxicol 52:51–56

    Google Scholar 

  • Barrett RJ, Lokhandwala MF (1981) Presynaptic dopamine receptor stimulation in the cardiovascular actions of lergotrile. J Pharmacol Exp Ther 217:660–665

    Google Scholar 

  • Begaud B, Dang Tran L, Montastruc JL, Montastruc P (1987) Antihypertensive effects of mesulergine: further evidence for a peripheral site of action of dopamine agonists. Fundam Clin Pharmacol 1:153–159

    Google Scholar 

  • Brooks DP, Weinstock J (1991) The pharmacology of pramipexole in the spontaneously hypertensive rat. Eur J Pharmacol 200:339–341

    Google Scholar 

  • Brown F, Mitchell P (1985) B-HT 920 is a dopamine agonist causing little or no motor hyperactivity, but is it a selective autoreceptor agonist? Br J Pharmacol 84:185P

  • Cavero I, Lefevre-Borg F, Gomeni R (1981) Heart rate lowering effects of N,N-di-n-propyl-dopamine in rats: evidence for stimulation of central dopamine receptors leading to inhibition of sympathetic tone and enhancement of parasympathetic outflow. J Pharmacol Exp Ther 219:510–519

    Google Scholar 

  • De Jonge A, Smit G, Thoolen MJMC, Timmermans PBMWM, Wilffert B, Van Zwieten PA (1984) Inhibitory dopamine receptors and α2-adrenoceptors on sympathetic neurons innervating the cardiovascular system of the rat. Br J Pharmacol 81:19P

  • Ennis C, Cox B (1980) The dopamine receptor antagonist domperidone is also a competitive antagonist at α1-adrenoceptors. J Pharm Pharmacol 32.434–435

    Google Scholar 

  • Eriksson E, Svennson K, Clark D (1985) The putative dopamine autoreceptor agonist B-HT 920 decreases nigral dopamine cell firing rate and prolactin release in rat. Life Sci 36:1819–1827

    Google Scholar 

  • Ferrari F, Baggio G, Mangiafïco V (1986) Lisuride-induced mounting and its modification by drugs active on adrenergic and dopaminergic receptors. Pharmacol Res Commun 18:1159–1168

    Google Scholar 

  • Grabowska-Anden M, Anden NE (1983) Stimulation of postsynaptic DA2 receptors produces jerks in reserpine-treated rats. J Pharm Pharmacol 35:543–545

    Google Scholar 

  • Hahn RA, MacDonald BR, Martin MA (1983) Antihypertensive activity of LY 141865, a selective presynaptic dopamine receptor agonist. J Pharmacol Exp Ther 224:206–214

    Google Scholar 

  • Hammer R, Kobinger W, Pichler L (1980) Binding of an imidazolidine (clonidine), an oxazoloazepin (B-HT 933) and a thiazoloazepin (BHT 920) to rat brain α-adrenoceptors and relation to cardiovascular effects. Eur J Pharmacol 62:277–285

    Google Scholar 

  • Hieble JP, Blumberg AL, Kinter LB, Demarinis RM, Owen DAA, Harvey CA (1989) Correlation of dopamine receptor selectivity and hemodynamic effects on the intact animal. In: Hieble JP (ed) Cardiovascular function of peripheral dopamine receptors. Marcel Dekker, New York, pp 177–204

    Google Scholar 

  • Hilditch A, Drew GM (1985) Peripheral dopamine receptor subtypes —a closer look. Trends Pharmacol Sci 6:396–400

    Google Scholar 

  • Hoefke W, Jennewein HM (1981) Mechanisms of antihypertensive action of clonidine in relation to its psychotropic effects. In: Lal H, Fieldings S (eds) Psychopharmacology of clonidine. Progress in clinical and biological research, vol 71. Alan Liss, New York, pp 75–97

    Google Scholar 

  • Hoefke W, Kobinger W (1966) Pharmakologische Wirkungen des 2-(2,6-Dichlor-phenylamino)-2-imidazolin-hydrochlorids, einer neuen antihypertensiven Substanz. Arzneim-Forsch/Drug Res 16:1038–1050

    Google Scholar 

  • Iorio LC, Houser V, Korduba CA, Leitz F, Barnett A (1981) SCH23 390, a benzazepine with atypical effects on dopaminergic systems. Pharmacologist 23:136

    Google Scholar 

  • Kobinger W, Pichler L (1980) Investigation into different types of postand presynaptic α-adrenoceptors at cardiovascular sites in rats. Eur J Pharmacol 65:393–402

    Google Scholar 

  • Kobinger W, Pichler L (1981a) α1- and α2-Adrenoceptor subtypes: selectivity of various agonists and relative distribution of receptors as determined in rats. Eur J Pharmacol 73:313–321

    Google Scholar 

  • Kobinger W, Pichler L (1981b) α2-Adrenoceptor agonistic effect of BHT 920 in isolated perfused hindquarters of rats. Eur J Pharmacol 76:101–105

    Google Scholar 

  • Kobinger W, Pichler L (1982) α-Adrenoceptor subtypes in cardiovascular regulation. J Cardiovasc Pharmacol 4:S-81-S-85

    Google Scholar 

  • Kobinger W, Lillie C, Pichler L (1980) Central cardiovascular α-adrenoceptors, relation to peripheral receptors. Circ Res 46:I-21-I-25

    Google Scholar 

  • Laduron PM, Leysen JE (1979) Domperidone, a specific in vitro dopamine antagonist, devoid of in vivo central dopaminergic activity. Biochem Pharmacol 28:2161–2165

    Google Scholar 

  • Lokhandwala MIT (1979) Analysis of the effects of bromocriptine on blood pressure and sympathetic nerve function. Eur J Pharmacol 56:253–256

    Google Scholar 

  • Memo M, Sagheddu G, Carruba MO, Spano P (1985) Dihydroergotoxine decreases blood pressure in spontaneously hypertensive rats by interacting with peripheral dopamine receptors. Life Sci 36:1515–1522

    Google Scholar 

  • Peringer E, Jenner P, Donaldson IM, Marsden CD (1976) Metoclopramide and dopamine receptor blockade. Neuropharmacology 15:463–469

    Google Scholar 

  • Pichler L (1981) Determination of α12 specificity for various α-adrenoceptor agonists. Naunyn-Schmiedeberg's Arch Pharmacol 316:R56

    Google Scholar 

  • Pichler L, Kobinger W (1981 a) Centrally mediated cardiovascular effects of B-HT 920 (6-allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazolo[4,5-d]-azepine dihydrochloride), a hypotensive agent of the “clonidine type”. J Cardiovasc Pharmacol 3:269–277

    Google Scholar 

  • Pichler L, Kobinger W (1981b) Modulation of motor activity by α1, and α2-adrenoceptor stimulation in mice. Naunyn-Schmiedeberg's Arch Pharmacol 317:180–182

    Google Scholar 

  • Schmitt H, Schmitt H, Fénard S (1971) Evidence for an α-sympathomimetic component in the effects of catapresan on vasomotor centres: antagonism by piperoxane. Eur J Pharmacol 14:98–100

    Google Scholar 

  • Schmitt H, Schmitt H, Fenard S (1973) Action of α-adrenergic blocking drugs on the sympathetic centres and their interactions with the central sympatho-inhibitory effect of clonidine. Arzneim-Forsch/Drug Res 23:40–44

    Google Scholar 

  • Spedding M (1980) Effects of metoclopramide and isoprenaline in the rat vas deferens; interactions with a-adrenoceptors. Br J Pharmacol 71:113–120

    Google Scholar 

  • Timmermans PBMWM, Lam E, Van Zwieten PA (1979) The interaction between prazosin and clonidine at α-adrenoceptors in rats and cats. Eur J Pharmacol 55:57–66

    Google Scholar 

  • Yen TT, Stamm NB, Clemens JA (1979) Pergolide: a potent dopaminergic antihypertensive. Life Sci 25:209–216

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Parts of the results were presented at the 33rd Spring Meeting of the German Pharmacological and Toxicological Society in Mainz, March 10–12, 1992 (Palluk R, Schilling JC, Stockhaus K, Peil H (1992) Naunyn-Schmiedeberg's Arch Pharmacol 345:R82)

Correspondence to R. Palluk at the above address

Rights and permissions

Reprints and permissions

About this article

Cite this article

Palluk, R., Schilling, J.C., Stockhaus, K. et al. Hypotensive and bradycardic effects of talipexole (B-HT 920) in anaesthetized rabbits are antagonized by metoclopramide but not by yohimbine. Naunyn-Schmiedeberg's Arch Pharmacol 348, 58–64 (1993). https://doi.org/10.1007/BF00168537

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00168537

Key words

Navigation